NovoCure's market cap is currently $2.39B. The company's EPS TTM is $-1.393; its P/E ratio is ―; NovoCure is scheduled to report earnings on February 27, 2025, and the estimated EPS forecast is $-0.34. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 509.34M	$ 537.84M	$ 535.03M	$ 494.37M	$ 351.32M
Gross Profit	$ 381.06M	$ 422.97M	$ 420.15M	$ 387.87M	$ 262.71M
Operating Income	$ -232.87M	$ -89.52M	$ -44.33M	$ 21.25M	$ -914.00K
EBITDA	$ -175.87M	$ -63.11M	$ -38.38M	$ 45.30M	$ 14.21M
Net Income	$ -207.04M	$ -92.53M	$ -58.35M	$ 19.81M	$ -7.23M
Balance Sheet
Cash & Short-Term Investments	$ 910.62M	$ 969.42M	$ 937.70M	$ 842.58M	$ 326.09M
Total Assets	$ 1.15B	$ 1.19B	$ 1.14B	$ 1.05B	$ 479.45M
Total Debt	$ 596.24M	$ 584.27M	$ 575.21M	$ 444.20M	$ 163.56M
Net Debt	$ 355.42M	$ 468.94M	$ 366.41M	$ 209.52M	$ -13.76M
Total Liabilities	$ 783.63M	$ 750.48M	$ 729.00M	$ 575.46M	$ 261.66M
Stockholders' Equity	$ 362.50M	$ 441.17M	$ 410.49M	$ 476.53M	$ 217.79M
Cash Flow
Free Cash Flow	$ -100.43M	$ 9.43M	$ 58.59M	$ 84.18M	$ 16.14M
Operating Cash Flow	$ -73.34M	$ 30.79M	$ 82.76M	$ 99.15M	$ 26.62M
Investing Cash Flow	$ 184.15M	$ -139.96M	$ -144.83M	$ -472.85M	$ -51.67M
Financing Cash Flow	$ 15.79M	$ 15.49M	$ 25.70M	$ 440.21M	$ 61.68M

Currency in USD

NovoCure Earnings and Revenue History

Income Statement >

NovoCure Debt to Assets

Balance Sheet >

NovoCure Cash Flow

Cash Flow >

NovoCure Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing